Oxygen supplementation ( DrugBank: Oxygen )


1 disease
IDDisease name (Link within this page)Number of trials
86Pulmonary arterial hypertension2

86. Pulmonary arterial hypertension


Clinical trials : 1,181 Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03683082
(ClinicalTrials.gov)
June 5, 201820/9/2018Oxygen Treatment and Pulmonary Arterial HypertensionAcute Effects of Oxygen Supplementation Among Pulmonary Arterial Hypertension PatientsPulmonary Arterial HypertensionDrug: Oxygen supplementation;Drug: Sham O2 (medical air)George Papanicolaou HospitalNULLUnknown status18 Years80 YearsAll10N/AGreece
2NCT02661802
(ClinicalTrials.gov)
January 201220/1/2016Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger SyndromeAcute Effects of 40% Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger SyndromeEisenmenger Complex;Hypertension, PulmonaryOther: Oxygen SupplementationFederal University of São PauloNULLCompleted18 Years60 YearsBoth30N/ANULL